ArticleJournal of managed care & specialty pharmacy2026
Economic evaluation of ponatinib vs reference and generic imatinib in front-line management of philadelphia chromosome-positive acute lymphoblastic leukemia: A value dilemma.
Rosemond Sussana Amamoo et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.